FDA Clearance Tracker · K192301
BIOEASY Marijuana Test Dip Card, BIOEASY Marijuana Test Strip
Last checked: Nov 19, 2026Latest source record: Sep 20, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Sep 20, 2019
Substantially Equivalent
Time to decision
28 days
Received Aug 23, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K192301
- Device name
- BIOEASY Marijuana Test Dip Card, BIOEASY Marijuana Test Strip
- Applicant location
- Shenzhen, CN
- Received
- Aug 23, 2019
- Decided
- Sep 20, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Cannabinoid, Over The Counter (NFW)
- Device class
- Class II
- Regulation
- 21 CFR 862.3870
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NFW. The earliest in FDA's data is K191924, decided Aug 16, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K192301
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Shenzhen Bioeasy Biotechnology Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230238 · Decided Mar 31, 2023 · 60 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
K193480 · Decided Jan 31, 2020 · 46 days after receipt
Device type: Test, Opiates, Over The Counter (NGL) · Laboratory Medicine & Pathology
K192515 · Decided Oct 11, 2019 · 28 days after receipt
Device type: Enzyme Immunoassay, Cannabinoids (LDJ) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.